Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

NCT04040231 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma
Pleural Mesothelioma
Wilms Tumor

Interventions

BIOLOGICAL: Galinpepimut-S
DRUG: Nivolumab
BIOLOGICAL: Sargramostim

Sponsor

Memorial Sloan Kettering Cancer Center